+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Drugs Market Research Reports

Non-Small Cell Lung Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 4664 Pages
From
Small-Cell Lung Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Small-Cell Lung Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1397 Pages
From
From
From
From
From
From
From
From
Non-Small Cell Lung Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Small Cell Lung Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
From
From
From
From
Loading Indicator

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

adroll 韩国a片-韩国三级片在线观看